Bionime 配当金
配当金 基準チェック /26
Bionime is a dividend paying company with a current yield of 2.79%.
主要情報
2.8%
配当利回り
-0.3%
バイバック利回り
| 総株主利回り | 2.5% |
| 将来の配当利回り | n/a |
| 配当成長 | 0.9% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | NT$2.000 |
| 配当性向 | -308% |
最近の配当金アップデート
Bionime (TWSE:4737) Is Reducing Its Dividend To NT$2
Jul 22
Bionime (TWSE:4737) Will Pay A Smaller Dividend Than Last Year
Jul 01Recent updates
Bionime (TWSE:4737) Is Reducing Its Dividend To NT$2
Jul 22Bionime (TWSE:4737) Will Pay A Smaller Dividend Than Last Year
Jul 01These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong
Apr 29Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?
Mar 23Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?
Mar 05Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?
Feb 15
Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet
Feb 01How Has Bionime (TPE:4737) Allocated Its Capital?
Jan 19A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE
Jan 06A Look At The Fair Value Of Bionime Corporation (TPE:4737)
Dec 22Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend
Dec 09Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Nov 24決済の安定と成長
配当データの取得
安定した配当: 4737's dividend payments have been volatile in the past 10 years.
増加する配当: 4737's dividend payments have increased over the past 10 years.
配当利回り対市場
| Bionime 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (4737) | 2.8% |
| 市場下位25% (TW) | 1.7% |
| 市場トップ25% (TW) | 4.4% |
| 業界平均 (Medical Equipment) | 2.8% |
| アナリスト予想 (4737) (最長3年) | n/a |
注目すべき配当: 4737's dividend (2.79%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).
高配当: 4737's dividend (2.79%) is low compared to the top 25% of dividend payers in the TW market (4.42%).
株主への利益配当
収益カバレッジ: 4737 is paying a dividend but the company is unprofitable.
株主配当金
キャッシュフローカバレッジ: 4737 is paying a dividend but the company has no free cash flows.